India, Nov. 12 -- Several biotech and healthcare stocks moved higher following significant financing developments, executive appointments, regulatory progress and quarterly financial results. Addex Therapeutics announced a $105 million financing for its spin-out Neurosterix, enGene strengthened its leadership team ahead of an anticipated regulatory filing, NeOnc Technologies secured an FDA meeting to discuss a potential accelerated approval pathway, and ProQR Therapeutics reported strong revenue growth and clinical development progress.
Read on.....Addex Therapeutics (ADXN)
Shares surged 71% after Addex Therapeutics announced that its spin-out company, Neurosterix, closed a $105 million Series B financing from a syndicate of leading life ...